血源紧张条件下血浆置换联合双重血浆分子吸附系统治疗早中期肝衰竭患者临床研究*

doi:10.3969/j.issn.1672-5069.2019.02.034

Abstract

Zhang Xiuling, Duan Zhiwen, Yang Ruidong, Zhang Xiaomin, Yang Li, Yang Haiqiu, Li Wu. Plasma exchange combined with double plasma molecular adsorption system in treatment of patients with liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 289-290.

References

[1] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版). 实用肝脏病杂志,2013,16(3);210-216.
[2] 中华医学会感染病学分会肝衰竭与人工肝学组. 非生物型人工肝治疗肝衰竭指南(2016年版). 中华临床感染病杂志,2016,9(2):97-103.
[3] Xu X,Liu X,Ling Q,et al.Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure. PLoS One,2013,8(3):e58738.
[4] Zhou P.Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system. World J Gastroenterol,2015,21(32):9614.
[5] Xia Q,Dai X,Huang J,et al.A single-center experience of non-bioartificial liver support systems among Chinese patients with liver failure. Int J Artif Organs,2014,37(6):442-454.
[6] Chen J,Huang J,Chen Y,et al.A clinical study on the treatment of severe hepatitis by a combined artificial liver. Hepatogastroenterology,2012,59(119):2273-2275.
[7] 何小凤,罗玲,袁春兰,等. 两种人工肝方法治疗重型乙型肝炎的近期疗效对比分析. 重庆医学,2017(18):2475-2477.
[8] 张晶,万华旭,段钟平,等. 血浆置换数学模型的建立和应用. 山东医药,2007,47(19):35-37.
[9] 孙潺,彭程,揭盛华,等. 羟乙基淀粉代血浆在人工肝支持系统中治疗肝衰竭的应用及安全性. 华中科技大学学报(医学版),2013,32(6):681-684.
[10] Wu Y,Wu A S,Wang J,et al.Effects of the novel 6% hydroxyethyl starch 130/0.4 on renal function of recipients in living-related kidney transplantation. Chin Med J (Engl),2010,123(21):3079-3083.
[11] 徐玉琴,石文明,李金顺,等. 代血浆加白蛋白置换液部分代替血浆进行人工肝治疗肝衰竭的临床观察. 中国急救医学,2013,33(9):829-831.

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[8]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[9]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[10]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[11]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[12]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[13]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[14]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[15]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.

Plasma exchange combined with double plasma molecular adsorption system in treatment of patients with liver failure

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments